Part ofpublic health →

FEDERALhearing transcript

High Impact

Congressional Hearing: Youth Vaping Epidemic in America

Original title: AN EPIDEMIC CONTINUES: YOUTH VAPING IN AMERICA

January 1, 2021

public health youth vaping FDA e-cigarettes tobacco regulation consumer protection

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The hearing examines the FDA's regulatory oversight of e-cigarette products, which directly impacts the availability of vaping devices and the legal standards for marketing them to minors.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Youth (Middle and High School Students)

This demographic is the primary focus of the public health concerns regarding vaping prevalence.

JUUL

The company is subject to FDA regulatory review and congressional investigation regarding its marketing practices.

Food and Drug Administration

The agency is responsible for the approval process and regulatory oversight of e-cigarette products.

What changed

Last recorded activity January 1, 2021.

What's next

Next step not available in the current record.

Summary

The House Subcommittee on Economic and Consumer Policy held a hearing to address the ongoing youth vaping epidemic. The committee reviewed evidence regarding marketing practices by e-cigarette companies, specifically JUUL, and discussed the FDA's role in regulating these products.

Key Facts

The hearing was the fourth conducted by the subcommittee regarding the youth vaping epidemic.
Data cited indicates that over 20 percent of high school students and 5 percent of middle school students use vaping products.
The Surgeon General declared youth vaping an epidemic in 2018.
The FDA previously issued a warning letter to JUUL declaring certain marketing practices illegal.
All e-cigarette products currently require FDA approval to remain on the market.
The subcommittee entered internal JUUL documents into the record, including marketing strategies and information regarding a 'Youth Advisory Council'.
Chairman Krishnamoorthi submitted formal 'Questions for the Record' to Acting Commissioner Woodcock.

Frequently Asked Questions

What is the purpose of this hearing?

The hearing was held to investigate the ongoing youth vaping epidemic and to review the FDA's regulatory actions regarding e-cigarette companies.

Are e-cigarettes currently regulated by the FDA?

Yes, e-cigarette products require FDA approval to remain on the market.

Why It Matters

The hearing examines the FDA's regulatory oversight of e-cigarette products, which directly impacts the availability of vaping devices and the legal standards for marketing them to minors.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Increased FDA Oversight

The hearing highlights a transition toward stricter FDA approval requirements for all e-cigarette products to remain on the market.

Food and Drug Administration JUUL

Connected Entities

personJanet Woodcock“Acting Commissioner of the Food and Drug Administration”Map →

personRaja Krishnamoorthi“Chairman of the Subcommittee on Economic and Consumer Policy”Map →

organizationFood and Drug Administration“Federal agency responsible for regulating e-cigarette products”Map →

personRichard J. Durbin“United States Senator who provided testimony”Map →

organizationJUUL“E-cigarette company under investigation for marketing practices”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance75
How much this matters to a regular citizen
Controversy60
Intensity of disagreement among stakeholders
Entertainment30
Compellingness for a non-policy-wonk reader
Buzz40
Current news / social attention level

Publisher tools